申玉英. 孟鲁司特联合布地奈德治疗重度哮喘的临床研究[J]. 实用临床医药杂志, 2006, (11): 47-49,58. DOI: 10.3969/j.issn.1672-2353.2006.11.015
引用本文: 申玉英. 孟鲁司特联合布地奈德治疗重度哮喘的临床研究[J]. 实用临床医药杂志, 2006, (11): 47-49,58. DOI: 10.3969/j.issn.1672-2353.2006.11.015
SHEN Yu-ying. CLINICAL STUDY OF TREATING SEVERE ASTHMA WITH MONTELUKAST ANDBUDESONIDE[J]. Journal of Clinical Medicine in Practice, 2006, (11): 47-49,58. DOI: 10.3969/j.issn.1672-2353.2006.11.015
Citation: SHEN Yu-ying. CLINICAL STUDY OF TREATING SEVERE ASTHMA WITH MONTELUKAST ANDBUDESONIDE[J]. Journal of Clinical Medicine in Practice, 2006, (11): 47-49,58. DOI: 10.3969/j.issn.1672-2353.2006.11.015

孟鲁司特联合布地奈德治疗重度哮喘的临床研究

CLINICAL STUDY OF TREATING SEVERE ASTHMA WITH MONTELUKAST ANDBUDESONIDE

  • 摘要: 目的 了解孟鲁司特联合吸入布地奈德治疗重度哮喘的疗效.方法 孟鲁司特联合吸入布地奈德治疗30例重度哮喘患者,根据纳入和排除标准筛选病例,据疗效判断标准进行临床疗效的判断.结果 孟鲁司特联合吸入布地奈德治疗30例重度哮喘6周后,治疗前早、晚间PEF, 治疗前早、晚间喘乐宁气雾剂喷数,治疗前日、夜间哮喘症状评分和治疗后相比具有显著性差异(P<0.01).结论 孟鲁司特联合吸入布地奈德治疗重度哮喘有效.

     

/

返回文章
返回